Literature DB >> 17555827

Genotyping of varicella-zoster virus strains after serial passages in cell culture.

Andreas Sauerbrei1, Anja Philipps, Roland Zell, Peter Wutzler.   

Abstract

There is little information in the literature about the stability of single nucleotide polymorphisms (SNP) used for genotyping of varicella-zoster virus (VZV) in sequencing studies. The objective of this study was to genotype VZV wild-type and vaccine isolates representing the four major clades A, B, C and J before and after serial passages in cell culture. Eleven VZV strains were genotyped by sequencing of the open reading frames (ORF) 1, 21, 37, 50, 54 and 60 as well as by restriction fragment length polymorphism (RFLP) analysis of the ORFs 38 and 62 after 1-16 passages in human embryonic lung fibroblasts (HELF). Results revealed no variations of nucleotide sequences in the ORFs 1, 21, 37, 50, 54 and 60 within 16 cell culture passages. Additionally, there were no changes in the RFLP profile of the ORFs 38 and 62. In conclusion, VZV can be isolated in HELF and propagated for at least 16 passages before genotyping by sequencing without the risk of intra-strain variations. For rapid diagnostic identification of vaccine versus wild-type strains, the RFLP profile that is stable within several cell culture passages can be determined using DNA prepared from clinical specimens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17555827     DOI: 10.1016/j.jviromet.2007.05.004

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  5 in total

1.  Monitoring prevalence of varicella-zoster virus clades in Germany.

Authors:  A Sauerbrei; J Stefanski; A Philipps; A Krumbholz; R Zell; P Wutzler
Journal:  Med Microbiol Immunol       Date:  2010-10-31       Impact factor: 3.402

2.  Sequencing of 21 varicella-zoster virus genomes reveals two novel genotypes and evidence of recombination.

Authors:  Roland Zell; Stefan Taudien; Florian Pfaff; Peter Wutzler; Matthias Platzer; Andreas Sauerbrei
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

3.  Targeted Genome Sequencing Reveals Varicella-Zoster Virus Open Reading Frame 12 Deletion.

Authors:  Randall J Cohrs; Katherine S Lee; Addilynn Beach; Bridget Sanford; Nicholas L Baird; Christina Como; Chiharu Graybill; Dallas Jones; Eden Tekeste; Mitchell Ballard; Xiaomi Chen; David Yalacki; Seth Frietze; Kenneth Jones; Tihana Lenac Rovis; Stipan Jonjić; Jürgen Haas; Don Gilden
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

4.  Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate.

Authors:  Anne-Kathrin Brunnemann; Kathrin Bohn-Wippert; Roland Zell; Andreas Henke; Martin Walther; Oliver Braum; Gregor Maschkowitz; Helmut Fickenscher; Andreas Sauerbrei; Andi Krumbholz
Journal:  Antimicrob Agents Chemother       Date:  2015-02-23       Impact factor: 5.191

5.  Variability of immediate-early gene 62 in german varicella-zoster virus wild-type strains.

Authors:  A Sauerbrei; K Bohn; R Zell; P Wutzler
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.